Highlands oncology Group, PA — Springdale, Arkansas

Highlands oncology Group, PA is a clinical research site located in Springdale, Arkansas, United States 72764.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Highlands oncology Group, PA has participated in 1 clinical trials.

Therapeutic areas: Metastatic Renal Cell Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Highlands oncology Group, PA?

Highlands oncology Group, PA has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Highlands oncology Group, PA conducted?

Highlands oncology Group, PA has 1 clinical trials on record. Their work covers Metastatic Renal Cell Cancer.

Is Highlands oncology Group, PA accredited by Crixeo Health?

Highlands oncology Group, PA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Highlands oncology Group, PA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.